

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 6.68075523 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.62532926 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.42876369 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.42876369 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 6.19201737 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.06220544 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 6.06220544 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.88390315 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.49235889 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.49235889 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.49235889 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 5.47717572 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42672089 |
| 14 | omega-hydroxylase P450 pathway (GO:0097267) | 5.39075907 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.38440829 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.34857336 |
| 17 | cysteine metabolic process (GO:0006534) | 5.14046238 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.11832383 |
| 19 | reverse cholesterol transport (GO:0043691) | 5.11392525 |
| 20 | regulation of cholesterol esterification (GO:0010872) | 5.04572417 |
| 21 | urea cycle (GO:0000050) | 4.98791124 |
| 22 | urea metabolic process (GO:0019627) | 4.98791124 |
| 23 | glyoxylate metabolic process (GO:0046487) | 4.94395396 |
| 24 | protein-lipid complex remodeling (GO:0034368) | 4.93937202 |
| 25 | macromolecular complex remodeling (GO:0034367) | 4.93937202 |
| 26 | plasma lipoprotein particle remodeling (GO:0034369) | 4.93937202 |
| 27 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.93484669 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.92963033 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.82274411 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.78968974 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.77038538 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.76427289 |
| 33 | phospholipid efflux (GO:0033700) | 4.74084197 |
| 34 | drug metabolic process (GO:0017144) | 4.73225961 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.64009284 |
| 36 | low-density lipoprotein particle remodeling (GO:0034374) | 4.60763349 |
| 37 | regulation of complement activation (GO:0030449) | 4.57669111 |
| 38 | bile acid metabolic process (GO:0008206) | 4.57527213 |
| 39 | negative regulation of lipase activity (GO:0060192) | 4.55569693 |
| 40 | regulation of plasminogen activation (GO:0010755) | 4.54529592 |
| 41 | nitrogen cycle metabolic process (GO:0071941) | 4.54070079 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 4.52617813 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.52617813 |
| 44 | serine family amino acid catabolic process (GO:0009071) | 4.49056895 |
| 45 | oxidative demethylation (GO:0070989) | 4.47791989 |
| 46 | protein carboxylation (GO:0018214) | 4.47326424 |
| 47 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.47326424 |
| 48 | plasma lipoprotein particle assembly (GO:0034377) | 4.47058623 |
| 49 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.46159238 |
| 50 | hormone catabolic process (GO:0042447) | 4.41503721 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.40064114 |
| 52 | phenylpropanoid metabolic process (GO:0009698) | 4.39124332 |
| 53 | glutamate metabolic process (GO:0006536) | 4.37281553 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.34803248 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.23153705 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.23153705 |
| 57 | cholesterol efflux (GO:0033344) | 4.22691718 |
| 58 | negative regulation of hemostasis (GO:1900047) | 4.21850364 |
| 59 | negative regulation of blood coagulation (GO:0030195) | 4.21850364 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 4.18812705 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.18130837 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 4.17724195 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.15260084 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.14431161 |
| 65 | alpha-amino acid catabolic process (GO:1901606) | 4.11126422 |
| 66 | cellular glucuronidation (GO:0052695) | 4.03107084 |
| 67 | lysine metabolic process (GO:0006553) | 4.02867460 |
| 68 | lysine catabolic process (GO:0006554) | 4.02867460 |
| 69 | plasma lipoprotein particle organization (GO:0071827) | 4.01873815 |
| 70 | ethanol oxidation (GO:0006069) | 3.97313327 |
| 71 | coenzyme catabolic process (GO:0009109) | 3.96373407 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 3.96076379 |
| 73 | tyrosine metabolic process (GO:0006570) | 3.95799172 |
| 74 | protein-lipid complex assembly (GO:0065005) | 3.94523377 |
| 75 | proline metabolic process (GO:0006560) | 3.94283055 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 3.92255676 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 3.87394996 |
| 78 | amine catabolic process (GO:0009310) | 3.87394996 |
| 79 | negative regulation of coagulation (GO:0050819) | 3.85786037 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 3.83135480 |
| 81 | regulation of cholesterol homeostasis (GO:2000188) | 3.82755169 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.82322290 |
| 83 | cellular amino acid catabolic process (GO:0009063) | 3.82012823 |
| 84 | S-adenosylmethionine metabolic process (GO:0046500) | 3.78066867 |
| 85 | protein-lipid complex subunit organization (GO:0071825) | 3.74284628 |
| 86 | heme transport (GO:0015886) | 3.73848121 |
| 87 | negative regulation of wound healing (GO:0061045) | 3.72928041 |
| 88 | phospholipid homeostasis (GO:0055091) | 3.69181697 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.67126574 |
| 90 | ethanol metabolic process (GO:0006067) | 3.66773173 |
| 91 | flavonoid metabolic process (GO:0009812) | 3.65828820 |
| 92 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65452325 |
| 93 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.64053324 |
| 94 | glycine metabolic process (GO:0006544) | 3.63986406 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.63702556 |
| 96 | drug catabolic process (GO:0042737) | 3.63274752 |
| 97 | positive regulation of hemostasis (GO:1900048) | 3.62056627 |
| 98 | positive regulation of blood coagulation (GO:0030194) | 3.62056627 |
| 99 | regulation of humoral immune response (GO:0002920) | 3.61631957 |
| 100 | intestinal cholesterol absorption (GO:0030299) | 3.60420613 |
| 101 | arginine metabolic process (GO:0006525) | 3.57918219 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.57228717 |
| 103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.57228717 |
| 104 | ketone body metabolic process (GO:1902224) | 3.56503390 |
| 105 | glucuronate metabolic process (GO:0019585) | 3.52900022 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.52900022 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.52834322 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 3.51999436 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.50109925 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.48619394 |
| 111 | benzene-containing compound metabolic process (GO:0042537) | 3.47245748 |
| 112 | sterol homeostasis (GO:0055092) | 3.46986138 |
| 113 | complement activation, classical pathway (GO:0006958) | 3.41983575 |
| 114 | cholesterol transport (GO:0030301) | 3.40732148 |
| 115 | sterol transport (GO:0015918) | 3.40732148 |
| 116 | sodium-independent organic anion transport (GO:0043252) | 3.40488109 |
| 117 | alkaloid metabolic process (GO:0009820) | 3.40072033 |
| 118 | protein activation cascade (GO:0072376) | 3.39904724 |
| 119 | fibrinolysis (GO:0042730) | 3.39606757 |
| 120 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.39006738 |
| 121 | regulation of cholesterol metabolic process (GO:0090181) | 3.39000796 |
| 122 | acute-phase response (GO:0006953) | 3.38775998 |
| 123 | cytolysis (GO:0019835) | 3.38186585 |
| 124 | blood coagulation, intrinsic pathway (GO:0007597) | 3.37180983 |
| 125 | urate metabolic process (GO:0046415) | 3.36667598 |
| 126 | negative regulation of protein activation cascade (GO:2000258) | 3.35990047 |
| 127 | positive regulation of coagulation (GO:0050820) | 3.33791616 |
| 128 | complement activation (GO:0006956) | 3.33492676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.87911175 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.91408761 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.62309248 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.47766686 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.64036694 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.70196313 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.59741424 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.46725366 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87702616 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.76130159 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.00213603 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0954085 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.87835681 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.84787273 |
| 15 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80180808 |
| 16 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.72310153 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58110083 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57419123 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54800950 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53406759 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47809854 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45601077 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.34594729 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33810534 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30327009 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29304801 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28876383 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28794701 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25956964 |
| 30 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21992833 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21963019 |
| 32 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21436071 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19767056 |
| 34 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.19193949 |
| 35 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19180835 |
| 36 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.16861582 |
| 37 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14447908 |
| 38 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13965335 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11339083 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11319943 |
| 41 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11312137 |
| 42 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.11141356 |
| 43 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.10667987 |
| 44 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09480763 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09232680 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09166023 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08221704 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08079014 |
| 49 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06144159 |
| 50 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.04969808 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04440742 |
| 52 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.04362680 |
| 53 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.04205249 |
| 54 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02881599 |
| 55 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02881599 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02838368 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02055066 |
| 58 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01281023 |
| 59 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00200710 |
| 60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99861869 |
| 61 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.99613870 |
| 62 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98813731 |
| 63 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98677620 |
| 64 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.98333307 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98294121 |
| 66 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98103293 |
| 67 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.98090405 |
| 68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97879397 |
| 69 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97815241 |
| 70 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97064875 |
| 71 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.96831254 |
| 72 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96226405 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95919767 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95919767 |
| 75 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95369528 |
| 76 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95291522 |
| 77 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.94714305 |
| 78 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.94102888 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94023737 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93629016 |
| 81 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93141945 |
| 82 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90949455 |
| 83 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.88952285 |
| 84 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88621880 |
| 85 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88514825 |
| 86 | FUS_26573619_Chip-Seq_HEK293_Human | 0.86790108 |
| 87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86354669 |
| 88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85975716 |
| 89 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85486618 |
| 90 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85460153 |
| 91 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.85248032 |
| 92 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84874117 |
| 93 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84844642 |
| 94 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84497873 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84171329 |
| 96 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84166967 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84103121 |
| 98 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.83765479 |
| 99 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.82908011 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82705681 |
| 101 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82168638 |
| 102 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.81844173 |
| 103 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.81801297 |
| 104 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81139443 |
| 105 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81031031 |
| 106 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.80692860 |
| 107 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.80692860 |
| 108 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80530183 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80046898 |
| 110 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.80035273 |
| 111 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.79932706 |
| 112 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79891661 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78680389 |
| 114 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77994285 |
| 115 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77994285 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76810505 |
| 117 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75587746 |
| 118 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.74315417 |
| 119 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74161010 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.73814694 |
| 121 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.73534920 |
| 122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73054325 |
| 123 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.72964522 |
| 124 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.72913622 |
| 125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.72826044 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.72319992 |
| 127 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.72301003 |
| 128 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.72240903 |
| 129 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.71280202 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69015059 |
| 131 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68219157 |
| 132 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.64666929 |
| 133 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.64384969 |
| 134 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.63781991 |
| 135 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62916070 |
| 136 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.62667051 |
| 137 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.62020033 |
| 138 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.61468717 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60622425 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.60191222 |
| 141 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59938536 |
| 142 | AR_25329375_ChIP-Seq_VCAP_Human | 0.58323760 |
| 143 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.58100503 |
| 144 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.57900228 |
| 145 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.57721385 |
| 146 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57345333 |
| 147 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.57092410 |
| 148 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56980014 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.56692973 |
| 150 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.56592625 |
| 151 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.56293682 |
| 152 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.56123029 |
| 153 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.55899855 |
| 154 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.55788988 |
| 155 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.55530947 |
| 156 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.55430237 |
| 157 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.55395700 |
| 158 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.55131014 |
| 159 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.54700926 |
| 160 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.54509504 |
| 161 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53765146 |
| 162 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.53591716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.82598114 |
| 2 | MP0005360_urolithiasis | 7.62474977 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.09876612 |
| 4 | MP0005365_abnormal_bile_salt | 5.54303976 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73417790 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.95106546 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.70334273 |
| 8 | MP0003252_abnormal_bile_duct | 3.67286624 |
| 9 | MP0009840_abnormal_foam_cell | 3.23013870 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.92820528 |
| 11 | MP0005083_abnormal_biliary_tract | 2.87183296 |
| 12 | MP0005332_abnormal_amino_acid | 2.57693514 |
| 13 | MP0002822_catalepsy | 2.31534530 |
| 14 | MP0003195_calcinosis | 2.20224898 |
| 15 | MP0000566_synostosis | 2.19622405 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 2.10189555 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.07725417 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.02147972 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.00555982 |
| 20 | MP0000609_abnormal_liver_physiology | 1.92690930 |
| 21 | MP0003868_abnormal_feces_composition | 1.70085318 |
| 22 | MP0009697_abnormal_copulation | 1.64099763 |
| 23 | MP0005408_hypopigmentation | 1.60365787 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56119749 |
| 25 | MP0002254_reproductive_system_inflammat | 1.54395392 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.52941850 |
| 27 | MP0004147_increased_porphyrin_level | 1.50965018 |
| 28 | MP0003011_delayed_dark_adaptation | 1.50428458 |
| 29 | MP0001764_abnormal_homeostasis | 1.42890976 |
| 30 | MP0003122_maternal_imprinting | 1.41809220 |
| 31 | MP0003690_abnormal_glial_cell | 1.35975252 |
| 32 | MP0000604_amyloidosis | 1.27571989 |
| 33 | MP0003329_amyloid_beta_deposits | 1.19471307 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.19286867 |
| 35 | MP0005647_abnormal_sex_gland | 1.15032533 |
| 36 | MP0009384_cardiac_valve_regurgitation | 1.06537207 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 1.00957895 |
| 38 | MP0009764_decreased_sensitivity_to | 0.97741560 |
| 39 | MP0009643_abnormal_urine_homeostasis | 0.97484953 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 0.95818442 |
| 41 | MP0003718_maternal_effect | 0.95231884 |
| 42 | MP0002132_abnormal_respiratory_system | 0.92211816 |
| 43 | MP0002282_abnormal_trachea_morphology | 0.91141278 |
| 44 | MP0001984_abnormal_olfaction | 0.90719680 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.87539383 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 0.85269385 |
| 47 | MP0000598_abnormal_liver_morphology | 0.85172901 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 0.85150010 |
| 49 | MP0005535_abnormal_body_temperature | 0.84643136 |
| 50 | MP0005646_abnormal_pituitary_gland | 0.84240744 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 0.80895927 |
| 52 | MP0005395_other_phenotype | 0.79580376 |
| 53 | MP0005410_abnormal_fertilization | 0.79384742 |
| 54 | MP0001915_intracranial_hemorrhage | 0.79175377 |
| 55 | MP0009642_abnormal_blood_homeostasis | 0.78361897 |
| 56 | MP0005187_abnormal_penis_morphology | 0.77166858 |
| 57 | MP0003075_altered_response_to | 0.76858662 |
| 58 | MP0003186_abnormal_redox_activity | 0.75500941 |
| 59 | MP0005376_homeostasis/metabolism_phenot | 0.75460580 |
| 60 | MP0009763_increased_sensitivity_to | 0.74142900 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.73993340 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.73869523 |
| 63 | MP0005451_abnormal_body_composition | 0.73132550 |
| 64 | MP0005448_abnormal_energy_balance | 0.70354561 |
| 65 | MP0004130_abnormal_muscle_cell | 0.68479349 |
| 66 | MP0008872_abnormal_physiological_respon | 0.68478048 |
| 67 | MP0002971_abnormal_brown_adipose | 0.68230534 |
| 68 | MP0010368_abnormal_lymphatic_system | 0.64004742 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 0.63988023 |
| 70 | MP0001440_abnormal_grooming_behavior | 0.62011662 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.59600634 |
| 72 | MP0005166_decreased_susceptibility_to | 0.59382639 |
| 73 | MP0005334_abnormal_fat_pad | 0.58931847 |
| 74 | MP0000639_abnormal_adrenal_gland | 0.58799772 |
| 75 | MP0003633_abnormal_nervous_system | 0.58228699 |
| 76 | MP0005266_abnormal_metabolism | 0.58149893 |
| 77 | MP0004859_abnormal_synaptic_plasticity | 0.56870712 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.56414042 |
| 79 | MP0004885_abnormal_endolymph | 0.55911890 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 0.55687120 |
| 81 | MP0008469_abnormal_protein_level | 0.55045261 |
| 82 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54620497 |
| 83 | MP0008874_decreased_physiological_sensi | 0.53402712 |
| 84 | MP0005670_abnormal_white_adipose | 0.53059572 |
| 85 | MP0004043_abnormal_pH_regulation | 0.52715477 |
| 86 | MP0009053_abnormal_anal_canal | 0.52175705 |
| 87 | MP0003136_yellow_coat_color | 0.51958491 |
| 88 | MP0004858_abnormal_nervous_system | 0.51400697 |
| 89 | MP0002938_white_spotting | 0.50555146 |
| 90 | MP0009745_abnormal_behavioral_response | 0.50491738 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.48689380 |
| 92 | MP0001486_abnormal_startle_reflex | 0.48625095 |
| 93 | MP0003953_abnormal_hormone_level | 0.47821283 |
| 94 | MP0001661_extended_life_span | 0.47607957 |
| 95 | MP0001324_abnormal_eye_pigmentation | 0.46913387 |
| 96 | MP0002168_other_aberrant_phenotype | 0.46790273 |
| 97 | MP0003635_abnormal_synaptic_transmissio | 0.46288907 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 0.44222143 |
| 99 | MP0002736_abnormal_nociception_after | 0.44069086 |
| 100 | MP0001529_abnormal_vocalization | 0.43110854 |
| 101 | MP0009672_abnormal_birth_weight | 0.42799810 |
| 102 | MP0003631_nervous_system_phenotype | 0.42353243 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.41830112 |
| 104 | MP0002063_abnormal_learning/memory/cond | 0.41557927 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.41389587 |
| 106 | MP0001177_atelectasis | 0.41316915 |
| 107 | MP0003632_abnormal_nervous_system | 0.41221092 |
| 108 | MP0004142_abnormal_muscle_tone | 0.40742265 |
| 109 | MP0002090_abnormal_vision | 0.40715887 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.38890873 |
| 111 | MP0002909_abnormal_adrenal_gland | 0.38533275 |
| 112 | MP0002064_seizures | 0.38429100 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.38203227 |
| 114 | MP0004924_abnormal_behavior | 0.38203227 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.38177277 |
| 116 | MP0004270_analgesia | 0.38150867 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.37826233 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.37736647 |
| 119 | MP0006292_abnormal_olfactory_placode | 0.37723878 |
| 120 | MP0003698_abnormal_male_reproductive | 0.37663523 |
| 121 | MP0003879_abnormal_hair_cell | 0.37560219 |
| 122 | MP0002572_abnormal_emotion/affect_behav | 0.37140334 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.37058640 |
| 124 | MP0001502_abnormal_circadian_rhythm | 0.36916765 |
| 125 | MP0005164_abnormal_response_to | 0.36824416 |
| 126 | MP0004883_abnormal_blood_vessel | 0.36569417 |
| 127 | MP0002796_impaired_skin_barrier | 0.36401001 |
| 128 | MP0001929_abnormal_gametogenesis | 0.36332461 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.36291493 |
| 130 | MP0000920_abnormal_myelination | 0.35478812 |
| 131 | MP0003699_abnormal_female_reproductive | 0.35389290 |
| 132 | MP0002229_neurodegeneration | 0.34805892 |
| 133 | MP0001756_abnormal_urination | 0.34500062 |
| 134 | MP0009115_abnormal_fat_cell | 0.33558381 |
| 135 | MP0002089_abnormal_postnatal_growth/wei | 0.33404846 |
| 136 | MP0003943_abnormal_hepatobiliary_system | 0.33331094 |
| 137 | MP0002928_abnormal_bile_duct | 0.32913600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.23869435 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.67551767 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 6.23987369 |
| 4 | Xanthomatosis (HP:0000991) | 6.22335384 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.19050877 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.04865688 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.85850600 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.60704501 |
| 9 | Complement deficiency (HP:0004431) | 5.07461936 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.93776961 |
| 11 | Acanthocytosis (HP:0001927) | 4.46534861 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 4.46010548 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36354115 |
| 14 | Epidermoid cyst (HP:0200040) | 4.29795221 |
| 15 | Hyperglycinemia (HP:0002154) | 4.26618184 |
| 16 | Hyperammonemia (HP:0001987) | 4.18461688 |
| 17 | Joint hemorrhage (HP:0005261) | 4.15342869 |
| 18 | Fat malabsorption (HP:0002630) | 4.11154129 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05193958 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.02553442 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.95829377 |
| 22 | Hyperglycinuria (HP:0003108) | 3.93072487 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.88630965 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88630965 |
| 25 | Hyperbilirubinemia (HP:0002904) | 3.84699766 |
| 26 | Ketosis (HP:0001946) | 3.82745791 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.78931352 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.78250800 |
| 29 | Hypochromic microcytic anemia (HP:0004840) | 3.72429634 |
| 30 | Poikilocytosis (HP:0004447) | 3.70265040 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 3.68839998 |
| 32 | Abnormality of complement system (HP:0005339) | 3.55574721 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.52316540 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.51683016 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.12285298 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.07383872 |
| 37 | Spontaneous abortion (HP:0005268) | 3.05790282 |
| 38 | Cholelithiasis (HP:0001081) | 3.04703093 |
| 39 | Abnormal gallbladder morphology (HP:0012437) | 3.03221669 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.95356459 |
| 41 | Ketoacidosis (HP:0001993) | 2.93829790 |
| 42 | Steatorrhea (HP:0002570) | 2.89470130 |
| 43 | Osteomalacia (HP:0002749) | 2.86059901 |
| 44 | Delayed CNS myelination (HP:0002188) | 2.85553249 |
| 45 | Cholecystitis (HP:0001082) | 2.84448708 |
| 46 | Abnormal gallbladder physiology (HP:0012438) | 2.84448708 |
| 47 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.82607404 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.81467912 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.81177925 |
| 50 | Nephritis (HP:0000123) | 2.79464770 |
| 51 | Reticulocytosis (HP:0001923) | 2.72102776 |
| 52 | Metabolic acidosis (HP:0001942) | 2.69246205 |
| 53 | Hypoglycemic seizures (HP:0002173) | 2.67691463 |
| 54 | Myocardial infarction (HP:0001658) | 2.62478551 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 2.62281610 |
| 56 | Abnormality of the gallbladder (HP:0005264) | 2.61460491 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.61421687 |
| 58 | Confusion (HP:0001289) | 2.55181617 |
| 59 | Status epilepticus (HP:0002133) | 2.55127693 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.50500180 |
| 61 | Skin nodule (HP:0200036) | 2.50479439 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.49161167 |
| 63 | Glycosuria (HP:0003076) | 2.49161167 |
| 64 | Abnormality of glycolysis (HP:0004366) | 2.46534712 |
| 65 | Vascular calcification (HP:0004934) | 2.41255715 |
| 66 | Malnutrition (HP:0004395) | 2.40752720 |
| 67 | Amyloidosis (HP:0011034) | 2.38516577 |
| 68 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.35370286 |
| 69 | Bifid scrotum (HP:0000048) | 2.34845785 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.34446568 |
| 71 | Lethargy (HP:0001254) | 2.23007901 |
| 72 | Systemic lupus erythematosus (HP:0002725) | 2.22690298 |
| 73 | Gout (HP:0001997) | 2.20413702 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.18119965 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18119965 |
| 76 | Late onset (HP:0003584) | 2.16724957 |
| 77 | Neonatal onset (HP:0003623) | 2.14043890 |
| 78 | Brushfield spots (HP:0001088) | 2.11856749 |
| 79 | Enlarged kidneys (HP:0000105) | 2.11263983 |
| 80 | Mitral stenosis (HP:0001718) | 2.09368394 |
| 81 | Irritability (HP:0000737) | 2.09158101 |
| 82 | Hyperphosphaturia (HP:0003109) | 2.07749982 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.07252705 |
| 84 | Arthropathy (HP:0003040) | 2.03563249 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01736941 |
| 86 | Rickets (HP:0002748) | 1.99184591 |
| 87 | Fair hair (HP:0002286) | 1.98969347 |
| 88 | Facial shape deformation (HP:0011334) | 1.96899887 |
| 89 | Potter facies (HP:0002009) | 1.96899887 |
| 90 | Gingival bleeding (HP:0000225) | 1.95740346 |
| 91 | Hyperventilation (HP:0002883) | 1.95657091 |
| 92 | Spastic diplegia (HP:0001264) | 1.95265842 |
| 93 | Vomiting (HP:0002013) | 1.92987342 |
| 94 | Hydroxyprolinuria (HP:0003080) | 1.88992483 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 1.88992483 |
| 96 | Glomerulonephritis (HP:0000099) | 1.88822764 |
| 97 | Esophageal varix (HP:0002040) | 1.88588541 |
| 98 | Thrombophlebitis (HP:0004418) | 1.82990088 |
| 99 | Bile duct proliferation (HP:0001408) | 1.79782504 |
| 100 | Abnormal biliary tract physiology (HP:0012439) | 1.79782504 |
| 101 | * Sensorimotor neuropathy (HP:0007141) | 1.79120884 |
| 102 | Pseudobulbar signs (HP:0002200) | 1.78951959 |
| 103 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78403337 |
| 104 | Symptomatic seizures (HP:0011145) | 1.78205671 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 1.77039387 |
| 106 | Cerebral edema (HP:0002181) | 1.76873822 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76817954 |
| 108 | Hemorrhage of the eye (HP:0011885) | 1.76688022 |
| 109 | Abnormality of vitamin metabolism (HP:0100508) | 1.76504913 |
| 110 | Hepatoblastoma (HP:0002884) | 1.76351576 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.75229335 |
| 112 | Pancreatitis (HP:0001733) | 1.75089836 |
| 113 | Back pain (HP:0003418) | 1.71214733 |
| 114 | Proximal tubulopathy (HP:0000114) | 1.70019870 |
| 115 | Chronic hepatic failure (HP:0100626) | 1.69859388 |
| 116 | Opisthotonus (HP:0002179) | 1.69760429 |
| 117 | Menorrhagia (HP:0000132) | 1.68520066 |
| 118 | Abnormality of alanine metabolism (HP:0010916) | 1.67654811 |
| 119 | Hyperalaninemia (HP:0003348) | 1.67654811 |
| 120 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.67654811 |
| 121 | Neoplasm of the liver (HP:0002896) | 1.66425862 |
| 122 | Hypertriglyceridemia (HP:0002155) | 1.65683979 |
| 123 | Alacrima (HP:0000522) | 1.64384871 |
| 124 | Retinal atrophy (HP:0001105) | 1.62059390 |
| 125 | Abnormal urine phosphate concentration (HP:0012599) | 1.61238209 |
| 126 | Abnormal tarsal ossification (HP:0008369) | 1.59985957 |
| 127 | Megaloblastic anemia (HP:0001889) | 1.58921516 |
| 128 | Purpura (HP:0000979) | 1.52699342 |
| 129 | Renal cortical cysts (HP:0000803) | 1.51993080 |
| 130 | Pigmentary retinal degeneration (HP:0001146) | 1.48609078 |
| 131 | Abnormal delivery (HP:0001787) | 1.47461101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 4.39158989 |
| 2 | BCKDK | 4.33034398 |
| 3 | EPHA4 | 3.70349996 |
| 4 | PDK2 | 3.10904853 |
| 5 | FGFR4 | 2.87068283 |
| 6 | ERN1 | 2.78845060 |
| 7 | INSRR | 2.66873089 |
| 8 | ERBB4 | 2.66594800 |
| 9 | MAP2K4 | 2.47962889 |
| 10 | DAPK2 | 2.40153689 |
| 11 | PNCK | 2.34464822 |
| 12 | FGFR3 | 2.33734198 |
| 13 | EIF2AK1 | 2.32802780 |
| 14 | MST1R | 2.24698942 |
| 15 | MAP4K2 | 2.19112306 |
| 16 | TAOK3 | 2.13668511 |
| 17 | MAPK11 | 1.99096397 |
| 18 | NEK1 | 1.90379430 |
| 19 | WNK4 | 1.83307486 |
| 20 | LMTK2 | 1.80911348 |
| 21 | WNK3 | 1.80904716 |
| 22 | GRK6 | 1.78806206 |
| 23 | TNIK | 1.74470391 |
| 24 | ACVR1B | 1.69056704 |
| 25 | TBK1 | 1.56079172 |
| 26 | BCR | 1.55938827 |
| 27 | FRK | 1.51069596 |
| 28 | MAP3K4 | 1.50103667 |
| 29 | TRIB3 | 1.47175195 |
| 30 | MAPK12 | 1.45589896 |
| 31 | NTRK2 | 1.43272835 |
| 32 | SGK2 | 1.36852963 |
| 33 | TSSK6 | 1.35997596 |
| 34 | CCNB1 | 1.30843561 |
| 35 | RAF1 | 1.30259129 |
| 36 | PRKCG | 1.30136805 |
| 37 | SGK3 | 1.30060744 |
| 38 | PBK | 1.29501346 |
| 39 | EIF2AK3 | 1.26773666 |
| 40 | WEE1 | 1.26155996 |
| 41 | PHKG2 | 1.26035719 |
| 42 | PHKG1 | 1.26035719 |
| 43 | PRKAA2 | 1.24045904 |
| 44 | MAP3K7 | 1.23274384 |
| 45 | NTRK3 | 1.21663818 |
| 46 | MARK1 | 1.21464775 |
| 47 | PDPK1 | 1.21271270 |
| 48 | EPHA3 | 1.21053506 |
| 49 | FGFR2 | 1.19336244 |
| 50 | ERBB2 | 1.19296634 |
| 51 | FGFR1 | 1.15622112 |
| 52 | PLK4 | 1.14877148 |
| 53 | TAOK1 | 1.13810985 |
| 54 | SGK223 | 1.10418420 |
| 55 | SGK494 | 1.10418420 |
| 56 | PKN1 | 1.06677264 |
| 57 | PRKCZ | 1.04500112 |
| 58 | EPHB2 | 0.99402804 |
| 59 | MAPK7 | 0.98120055 |
| 60 | MAP2K7 | 0.96801187 |
| 61 | PRKACG | 0.96009396 |
| 62 | ZAK | 0.94790046 |
| 63 | BRSK2 | 0.94142998 |
| 64 | PINK1 | 0.93625524 |
| 65 | CAMK2G | 0.93430395 |
| 66 | PRKAA1 | 0.93038422 |
| 67 | SIK2 | 0.92325567 |
| 68 | ABL2 | 0.90991805 |
| 69 | CSNK1G1 | 0.90427343 |
| 70 | LATS1 | 0.87780380 |
| 71 | JAK2 | 0.87680730 |
| 72 | PTK6 | 0.85596853 |
| 73 | PIK3CG | 0.84943994 |
| 74 | CSNK1A1L | 0.84813262 |
| 75 | BMPR1B | 0.83880423 |
| 76 | MAPK4 | 0.80391249 |
| 77 | IKBKE | 0.79234246 |
| 78 | PDK1 | 0.78825505 |
| 79 | CAMKK1 | 0.78269917 |
| 80 | STK39 | 0.74280276 |
| 81 | AKT3 | 0.74113920 |
| 82 | TTK | 0.73236260 |
| 83 | CASK | 0.72503897 |
| 84 | TAOK2 | 0.70651589 |
| 85 | CAMK1G | 0.69592472 |
| 86 | MAPKAPK5 | 0.68969915 |
| 87 | MINK1 | 0.68667535 |
| 88 | KSR2 | 0.68483209 |
| 89 | CSNK1E | 0.66152319 |
| 90 | PRKACB | 0.64788060 |
| 91 | MAP3K13 | 0.64513580 |
| 92 | CSNK1D | 0.64447356 |
| 93 | CAMK1D | 0.64063927 |
| 94 | MET | 0.63561401 |
| 95 | PRKCA | 0.62689755 |
| 96 | ICK | 0.62422509 |
| 97 | PIK3CA | 0.62036272 |
| 98 | TYRO3 | 0.61911056 |
| 99 | MAP2K1 | 0.61585695 |
| 100 | CSNK1G3 | 0.61577507 |
| 101 | PKN2 | 0.61466377 |
| 102 | DYRK2 | 0.60420120 |
| 103 | CSNK1A1 | 0.59757988 |
| 104 | IRAK3 | 0.58476730 |
| 105 | PRKCQ | 0.58387276 |
| 106 | IGF1R | 0.57780744 |
| 107 | RPS6KA3 | 0.56014505 |
| 108 | CAMK2A | 0.55906725 |
| 109 | CDK5 | 0.55559725 |
| 110 | PAK3 | 0.53298080 |
| 111 | ARAF | 0.52643280 |
| 112 | CLK1 | 0.52455662 |
| 113 | CSNK1G2 | 0.51897116 |
| 114 | FER | 0.51357653 |
| 115 | MAPKAPK3 | 0.50495599 |
| 116 | STK11 | 0.50393196 |
| 117 | TYK2 | 0.48728367 |
| 118 | PRKCB | 0.48309769 |
| 119 | PRKCE | 0.48100510 |
| 120 | RET | 0.47731128 |
| 121 | SGK1 | 0.46690287 |
| 122 | MAPK15 | 0.46609527 |
| 123 | PLK2 | 0.46507901 |
| 124 | GRK1 | 0.45454302 |
| 125 | MAP3K2 | 0.45344816 |
| 126 | BMX | 0.43838994 |
| 127 | STK38L | 0.43813776 |
| 128 | KSR1 | 0.43424222 |
| 129 | MAP3K10 | 0.42931739 |
| 130 | WNK1 | 0.42094114 |
| 131 | DAPK1 | 0.41909100 |
| 132 | NTRK1 | 0.41835488 |
| 133 | MAP2K6 | 0.41152112 |
| 134 | SRPK1 | 0.40573915 |
| 135 | CSNK2A1 | 0.40434286 |
| 136 | RPS6KB1 | 0.39968486 |
| 137 | NEK2 | 0.39335592 |
| 138 | CDK6 | 0.39029533 |
| 139 | KDR | 0.38897749 |
| 140 | MAP3K12 | 0.38828336 |
| 141 | JAK1 | 0.38681655 |
| 142 | RIPK1 | 0.37883173 |
| 143 | PRKACA | 0.37545167 |
| 144 | MAPK13 | 0.37320796 |
| 145 | DYRK3 | 0.37075231 |
| 146 | CSNK2A2 | 0.36968863 |
| 147 | PTK2 | 0.36850684 |
| 148 | PRKG1 | 0.36164339 |
| 149 | DYRK1B | 0.35241282 |
| 150 | MAP3K1 | 0.35055764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.32904995 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.25514580 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.00673583 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90954817 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84675911 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65287540 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59210934 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51785866 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51046815 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.47228269 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33029245 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17164673 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16079902 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96490924 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91947171 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91862975 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.90661963 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.90475182 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89309566 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81113129 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77356423 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74943527 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74686094 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73692704 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70474692 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65973808 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62449690 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59985391 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56600551 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53069285 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50952258 |
| 32 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.48448296 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45937319 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45199005 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43550085 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40386556 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38192199 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.37722847 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.35692367 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32345356 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28336809 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27383212 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26323674 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25062683 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25036802 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.19942324 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15500688 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14512321 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11793527 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11561215 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08780268 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07702949 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04820140 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01993499 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98854966 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.96875584 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91095662 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82314830 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80308571 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79619882 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74982949 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74114979 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73869404 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.73324162 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51154499 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49727592 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48009954 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44949129 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42035375 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.40533551 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39255056 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37919053 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.36205586 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.30824086 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30012666 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.24833013 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.22633060 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.20880820 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19390084 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18739997 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18529993 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16862887 |
| 83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.14401506 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08299684 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08220136 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.04059881 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.03356891 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03103492 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02994291 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02722679 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.02009714 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.01287784 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | -0.1202149 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1108111 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | -0.1097835 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1065346 |
| 97 | Protein export_Homo sapiens_hsa03060 | -0.0886401 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0878304 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0838040 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0692546 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0680929 |
| 102 | Pertussis_Homo sapiens_hsa05133 | -0.0659469 |
| 103 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0642075 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0412398 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0270658 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0199815 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0164561 |
| 108 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0141517 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | -0.0131633 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | -0.0103404 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0039669 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0034545 |

